viernes, 7 de julio de 2023

FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval Action Follows Confirmatory Trial to Verify Clinical Benefit

https://www.fda.gov/news-events/press-announcements/fda-converts-novel-alzheimers-disease-treatment-traditional-approval?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario